Pages that link to "Q41731248"
Jump to navigation
Jump to search
The following pages link to Phosphorylation of mammalian DNA topoisomerase I and activation by protein kinase C. (Q41731248):
Displaying 26 items.
- Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1 and circadian period (Q24297026) (← links)
- Oxidative stress responses in Escherichia coli and Salmonella typhimurium (Q24634713) (← links)
- Decreased camptothecin sensitivity of the stem-cell-like fraction of Caco2 cells correlates with an altered phosphorylation pattern of topoisomerase I (Q28539951) (← links)
- Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro (Q28910347) (← links)
- The p14ARF alternate reading frame protein enhances DNA binding of topoisomerase I by interacting with the serine 506-phosphorylated core domain (Q31114576) (← links)
- Gene disruption of the DNA topoisomerase IB small subunit induces a non-viable phenotype in the hemoflagellate Leishmania major (Q33350046) (← links)
- DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde? (Q33734562) (← links)
- Targeting to transcriptionally active loci by the hydrophilic N-terminal domain of Drosophila DNA topoisomerase I. (Q33775078) (← links)
- SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I (Q34114381) (← links)
- CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity (Q34491446) (← links)
- Protein Kinase CK2 Is a Central Regulator of Topoisomerase I Hyperphosphorylation and Camptothecin Sensitivity in Cancer Cell Lines (Q34615210) (← links)
- Topoisomerase I inhibitors, shikonin and topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells (Q35058674) (← links)
- Topoisomerase-I PS506 as a Dual Function Cancer Biomarker (Q35738913) (← links)
- Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove (Q36390575) (← links)
- Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I (Q36711144) (← links)
- Topoisomerase I as a biomarker: detection of activity at the single molecule level. (Q37588708) (← links)
- Roles of eukaryotic topoisomerases in transcription, replication and genomic stability (Q38959828) (← links)
- Interleukin-2 induces the activities of DNA topoisomerase I and DNA topoisomerase II in HuT 78 cells (Q39789200) (← links)
- Topoisomerase I inhibitors and drug resistance (Q40028536) (← links)
- Topoisomerase inhibitors. A review of their therapeutic potential in cancer (Q40499871) (← links)
- Pea DNA topoisomerase I is phosphorylated and stimulated by casein kinase 2 and protein kinase C. (Q44545736) (← links)
- Phosphorylation of serine residues in the N-terminal domains of eukaryotic type I topoisomerases (Q47702086) (← links)
- Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor. (Q47878776) (← links)
- Specific regulatory role of phosphorylation of calf thymus DNA-topoisomerase I smaller forms on the relaxational activity expression. Phosphorylation role on Topo I smaller forms activity (Q67490206) (← links)
- PKA controls a level of topoisomerase I mRNA in mouse L5178Y lymphoma cells treated with db-cAMP (Q72155122) (← links)
- The predominant form of mammalian DNA topoisomerase I in vivo has a molecular mass of 100 kDa (Q72155123) (← links)